21 | Proteins (Proteins, Gene)FDA Link
05/2024
-
04/2005 |
7 | Immune Checkpoint InhibitorsIBA
01/2023
-
01/2020 |
7 | pterostilbeneIBA
01/2021
-
11/2016 |
6 | Biomarkers (Surrogate Marker)IBA
01/2023
-
05/2008 |
5 | DCZ3301IBA
12/2020
-
01/2017 |
4 | Blood Glucose (Blood Sugar)IBA
01/2017
-
09/2006 |
4 | Peptide Hydrolases (Proteases)FDA Link
08/2014
-
03/2005 |
3 | ErbB Receptors (EGF Receptor)IBA
03/2024
-
05/2004 |
3 | Phosphotransferases (Kinase)IBA
01/2024
-
04/2011 |
3 | Adenosine Triphosphate (ATP)IBA
12/2023
-
08/2005 |
3 | DCZ0358IBA
12/2023
-
01/2018 |
3 | Bortezomib (Velcade)FDA Link
11/2023
-
06/2020 |
3 | Retinaldehyde (Retinal)IBA
06/2022
-
02/2016 |
3 | VaccinesIBA
01/2022
-
06/2013 |
3 | LigandsIBA
01/2021
-
06/2007 |
3 | EnzymesIBA
10/2019
-
09/2006 |
3 | Amyloid (Amyloid Fibrils)IBA
10/2019
-
06/2007 |
3 | Sorafenib (BAY 43-9006)FDA Link
03/2019
-
01/2013 |
3 | LipidsIBA
01/2019
-
11/2010 |
3 | alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA
08/2017
-
08/2014 |
3 | Small Interfering RNA (siRNA)IBA
03/2015
-
06/2014 |
3 | Amyloid Precursor Protein Secretases (beta-Secretase)IBA
10/2010
-
03/2005 |
2 | Trastuzumab (Herceptin)FDA Link
01/2024
-
10/2018 |
2 | Etoposide (VP 16)FDA LinkGeneric
12/2023
-
01/2019 |
2 | Oxygen (Dioxygen)IBA
12/2022
-
12/2022 |
2 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2022
-
12/2022 |
2 | Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
05/2022
-
03/2016 |
2 | SincalideFDA Link
01/2022
-
08/2012 |
2 | Fatty Acids (Saturated Fatty Acids)IBA
11/2021
-
01/2015 |
2 | Therapeutic UsesIBA
10/2021
-
01/2020 |
2 | SiliconesIBA
01/2021
-
01/2020 |
2 | RafoxanideIBA
02/2020
-
01/2019 |
2 | Histone Deacetylase InhibitorsIBA
01/2020
-
05/2017 |
2 | PanobinostatIBA
01/2020
-
05/2017 |
2 | ATPases Associated with Diverse Cellular ActivitiesIBA
01/2020
-
04/2017 |
2 | Oncogene Proteins (Oncogene Protein)IBA
10/2018
-
05/2016 |
2 | 5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA
08/2018
-
11/2016 |
2 | Mechanistic Target of Rapamycin Complex 1IBA
08/2018
-
01/2018 |
2 | Protein Kinases (Protein Kinase)IBA
01/2017
-
11/2016 |
2 | Fatty Acid-Binding ProteinsIBA
01/2017
-
01/2015 |
2 | celastrolIBA
05/2016
-
02/2016 |
2 | Glucose (Dextrose)FDA LinkGeneric
01/2016
-
01/2013 |
2 | VemurafenibIBA
04/2014
-
01/2013 |
2 | STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
04/2013
-
04/2013 |
2 | Leukocyte Elastase (Neutrophil Elastase)IBA
01/2013
-
10/2012 |
2 | Insulin (Novolin)FDA Link
01/2013
-
11/2010 |
2 | Zanamivir (Relenza)FDA Link
08/2012
-
10/2006 |
2 | N-AcetylglucosaminyltransferasesIBA
08/2012
-
10/2011 |
2 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2011
-
05/2004 |
2 | Neuraminidase (Sialidase)IBA
09/2006
-
06/2006 |
2 | Enzyme Inhibitors (Inhibitors, Enzyme)IBA
05/2006
-
03/2005 |
1 | CollagenIBA
05/2024 |
1 | Atrial Natriuretic Factor (ANF)IBA
05/2024 |
1 | Doxorubicin (Adriamycin)FDA LinkGeneric
02/2024 |